NYSE: ZBHZimmer Biomet Holdings Inc Stock
$91.28-1.98 (-2.12%)
Updated Jun 13, 2025
ZBH Price
$91.28
Fair Value Price
N/A
Market Cap
$18.06B
52 Week Low
$89.22
52 Week High
$116.71
P/E
20.15x
P/B
1.46x
P/S
2.92x
PEG
0.83x
Dividend Yield
0.79%
Revenue
$7.70B
Earnings
$913.40M
Gross Margin
71.1%
Operating Margin
16.66%
Profit Margin
11.9%
Debt to Equity
0.79
Operating Cash Flow
$155M
Beta
0.7
Next Earnings
Aug 5, 2025
Ex-Dividend
Jun 26, 2025
Next Dividend
Jul 31, 2025
ZBH Overview
Zimmer Biomet Holdings Incorporated operates in the musculoskeletal healthcare sector in the U.S. and internationally. The company offers orthopaedic reconstructive products for knees and hips, as well as sports medicine, biologics, foot and ankle, extremities, and trauma products. Other offerings include spine (devices and surgical instruments) and face and skull reconstruction products.The company was known as Zimmer Holdings, Inc. until 2015/06. Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, IN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ZBH's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
ZBH
Ranked#36 of 108
Ranked#36 of 108
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $29.39 | A | |
| $12.10 | A | |
| $20.07 | A |
Be the first to know about important ZBH news, forecast changes, insider trades & much more!
ZBH News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZBH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZBH ($91.28) is trading above its intrinsic value of $63.65, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZBH is good value based on its earnings relative to its share price (20.15x), compared to the US market average (31.36x)
P/E vs Market Valuation
ZBH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ZBH due diligence checks available for Premium users.
Valuation
ZBH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
20.15x
Industry
35.6x
Market
31.36x
ZBH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ZBH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ZBH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.46x
Industry
3.99x
ZBH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZBH price to earnings growth (PEG)
For valuing profitable companies with growth potential
ZBH is good value based... subscribe to Premium to read more.
PEG Value Valuation
ZBH's financial health
Profit margin
Revenue
$1.9B
Net Income
$182.0M
Profit Margin
9.5%
ZBH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZBH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$22.2B
Liabilities
$9.8B
Debt to equity
0.79
ZBH's short-term assets ($5.59B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZBH's long-term liabilities ($7.49B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZBH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZBH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$382.8M
Investing
-$106.0M
Financing
$575.4M
ZBH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZBH vs Medical Device Stocks
Zimmer Biomet Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.